FDA Inspection 1008395 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 1000221279

The FDA completed an inspection of American Red Cross Blood Services on Apr 10, 2017 in Scranton, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 10, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Scranton, PA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.